Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data

• Andrea Giacomelli,
• Alessandro Cozzi-Lepri,
• Giacomo Casalini,
• Letizia Oreni,
• Anna Lisa Ridolfo,
• Spinello Antinori

Affiliations

Andrea Giacomelli

III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy; Correspondence to: III Infectious Diseases Unit, L. Sacco Hospital, Via G.B. Grassi 74, 20157 Milano, Italy.

Alessandro Cozzi-Lepri

Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK

Giacomo Casalini

III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Italy

Letizia Oreni

III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy

Anna Lisa Ridolfo

III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy

Spinello Antinori

III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Italy